ALPINE IMMUNE SCIENCES, INC. Marketable Securities (Current)
ALPINE IMMUNE SCIENCES, INC. had Marketable Securities (Current) of $21.95 million as of 2017-06-30, per its 10-Q filed 2017-07-21.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2017-07-21
- 2017-06-30: Marketable Securities, Current $21.95M.
- 2017-03-31: Marketable Securities, Current $39.74M.
- 2016-12-31: Marketable Securities, Current $36.83M.
- 2016-09-30: Marketable Securities, Current $50.02M.
| Period end | Marketable Securities, Current |
|---|---|
| 2017-06-30 | $21.95M 10-Q · filed 2017-07-21 |
| 2017-03-31 | $39.74M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $36.83M 10-Q · filed 2017-07-21 |
| 2016-09-30 | $50.02M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $58.32M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $64.18M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $62.26M 10-K · filed 2017-02-13 |
| 2015-09-30 | $35.10M 10-Q · filed 2015-11-03 |